Total Payments
$373.81
2024 Payments
$128.02
Companies
3
Transactions
20
Medicare Patients
1,478
Medicare Billing
$125,821
Payment Breakdown by Category
Food & Beverage$373.81 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $373.81 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $314.91 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $56.82 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $128.02 | 5 | ABBVIE INC. ($99.11) |
| 2023 | $164.47 | 9 | ABBVIE INC. ($136.56) |
| 2022 | $16.50 | 1 | ABBVIE INC. ($16.50) |
| 2021 | $64.82 | 5 | AbbVie Inc. ($62.74) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 331 | 412 | $97,936 | $29,750 |
| 2022 | 8 | 380 | 495 | $100,329 | $35,328 |
| 2021 | 8 | 385 | 496 | $87,075 | $33,811 |
| 2020 | 10 | 382 | 491 | $81,750 | $26,933 |
Total Patients
1,478
Total Services
1,894
Medicare Billing
$125,821
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $28,815 | $12,420 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 158 | $47,084 | $10,282 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 81 | $17,172 | $4,416 | 25.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,460 | $1,687 | 68.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,020 | $525.47 | 51.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,105 | $372.30 | 33.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 14 | $280.00 | $47.74 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 192 | $46,430 | $13,893 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $29,835 | $13,209 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 110 | $18,479 | $5,598 | 30.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,255 | $1,591 | 70.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $1,060 | $543.32 | 51.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 17 | 17 | $1,020 | $341.19 | 33.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $910.00 | $94.52 | 10.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 17 | $340.00 | $58.52 | 17.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 190 | $41,575 | $13,515 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 101 | 101 | $25,650 | $11,643 | 45.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 78 | $11,235 | $4,419 | 39.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 17 | 17 | $3,450 | $2,485 | 72.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 56 | 56 | $2,985 | $917.84 | 30.7% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 17 | 17 | $1,020 | $479.04 | 47.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $760.00 | $279.68 | 36.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 16 | 21 | $400.00 | $73.08 | 18.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 90 | 179 | $38,485 | $10,553 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 96 | 96 | $24,000 | $9,724 | 40.5% |
About Amy Coombs, ARNP
Amy Coombs, ARNP is a Registered Nurse healthcare provider based in Newington, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104914860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Coombs, ARNP has received a total of $373.81 in payments from pharmaceutical and medical device companies, with $128.02 received in 2024. These payments were reported across 20 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($373.81).
As a Medicare-enrolled provider, Coombs has provided services to 1,478 Medicare beneficiaries, totaling 1,894 services with total Medicare billing of $125,821. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Newington, NH
- Active Since 10/10/2006
- Last Updated 03/07/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1104914860
Products in Payments
- UBRELVY (Drug) $161.85
- VRAYLAR (Drug) $136.56
- INJECTAFER (Drug) $56.82
- QULIPTA (Drug) $16.50
- Xofluza (Drug) $2.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Newington
Elisabeth Robinson, Arnp, ARNP
Registered Nurse — Payments: $265.99
Registered Nurse $265.99
Mrs. Ellie Plukas Smith, R.n. , Aprn, Bc, R.N. , APRN, BC
Registered Nurse
Registered Nurse
Tom Stribula, R.n, R.N
Registered Nurse
Registered Nurse
Elaine Horowitz, Rn, RN
Registered Nurse
Registered Nurse
Robin Dexter, Rn, RN
Registered Nurse
Registered Nurse
Daniel Lantos, Rn, RN
Registered Nurse
Registered Nurse